UzAMBS and Dendrite Clinical Systems to establish National Registry of Bariatric and Metabolic Surgery of Uzbekistan
The Association of Bariatric and Metabolic Surgeons of Uzbekistan (UzAMBS) and Dendrite Clinical Systems will establish a National Registry of Bariatric and Metabolic Surgery of Uzbekistan. The purpose of the Registry is to collect information on patients and bariatric procedures in the country so researchers can use the data to improve outcomes in patients.

“The creation of a national bariatric registry will allow us to evaluate the technical characteristics of bariatric interventions performed in different centers, the geographical characteristics of the distribution of bariatric patients, track strategies for choosing types of surgical treatment, systematize data on the characteristics of management and clinical tactics, and evaluate long-term results,” explained President of UzAMBS, Professor Oktyabr Teshaev (Head of the Department of Surgery of the Tashkent Medical Academy, Tashkent, Uzbekistan).
The National Register of Bariatric Surgery of Uzbekistan will be financed by the members of UzAMBS and mainly collect the following data:
- data on all types of bariatric surgeries
- patient data before and after surgery
- general clinical and biochemical blood tests
- data from instrumental studies of ultrasound, X-Ray, MSCT, EGDFS, ECG, etc.
- selection of bariatric surgery method
- postoperative management
- postoperative observation with repeat examinations one, three, six, 12 and 24 months
- analysis of remote results of surgeries performed
- complications and quality of life after bariatrics
- data on bariatric surgeons
- performance indicators of surgical centres, as well as statistical processing of the obtained data and creation of reports
“Systemisation and unification of the results of bariatric interventions will allow us to audit and certify clinics, which will obviously improve the quality of bariatric care in the country. We analysed the activities of several companies in the field of programming and creating registers, but having studied the activities of Dendrite Clinical Systems and learned the structure of the IFSO Registry, we came to the conclusion that it would be right to entrust the creation of the National Register of Bariatric Surgeons of Uzbekistan to Dendrite,” he added.
About Dendrite
Dendrite Clinical Systems is a UK-headquartered international company with over a 30-year track record as a specialist provider of secure clinical registries, analysis software and consultancy services for the international healthcare sector, specifically for clinical research, multi-centre real-world studies, observational registries, international, national and hospital clinical databases.
Dendrite has been recognised as a leading provider of clinical registries across various specialties with a unique track record of implementing over 200 major clinical registry systems globally including systems for major research projects for medical device companies, CROs and pharmaceutical companies.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


